Skip to main content
Advertisement
Advertisement

AIM

AIM logo

AIM ImmunoTech Inc.

0.20
USD
Sponsored
-0.01
-3.19%
Sep 24, 15:27 UTC -4
Closed
exchange

Pre-Market

0.20

0.00
-0.15%

AIM Earnings Reports

Positive Surprise Ratio

AIM beat 14 of 32 last estimates.

44%

Next Report

Date of Next Report
Nov 16, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.13
Implied change from Q2 26 (Revenue/ EPS)
-100.00%
/
-69.77%
Implied change from Q3 25 (Revenue/ EPS)
-100.00%
/
-91.67%

AIM ImmunoTech Inc. earnings per share and revenue

On Aug 07, 2026, AIM reported earnings of -0.43 USD per share (EPS) for Q2 26, missing the estimate of -0.17 USD, resulting in a -150.44% surprise. Revenue reached 26.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -7.85% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an decrease of -69.77% EPS, and decrease of -100.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, AIM ImmunoTech Inc. reported EPS of -$0.43, missing estimates by -150.44%, and revenue of $26.00K, 0% as expectations.
The stock price moved down -7.85%, changed from $0.29 before the earnings release to $0.26 the day after.
The next earning report is scheduled for Nov 16, 2026.
Based on 3 analysts, AIM ImmunoTech Inc. is expected to report EPS of -$0.13 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement